Keyphrases
Breast Cancer
100%
Genomic Instability
100%
Pathway Expression
100%
Immune Infiltration
100%
CGAS-STING
100%
Inflammatory Pathways
37%
C-Myc
37%
Replication Stress
37%
H2AX
37%
ISTAT
25%
Cyclin E1
25%
Immune Checkpoint Inhibitors
12%
Clinical Trials
12%
Stress Markers
12%
Stress-related
12%
CD4 Cells
12%
Expression Level
12%
Signal Component
12%
Breast Cancer Patients
12%
Immune Markers
12%
Oncogene
12%
Response to Treatment
12%
Primary Breast Cancer
12%
CD57
12%
CD20
12%
JAK-STAT Pathway
12%
Stimulator of Interferon Genes (STING)
12%
Homologous Recombination Deficiency
12%
Combination Immunotherapy
12%
CD20+ Cells
12%
Pro-tumorigenic
12%
Triple-negative Breast Cancer
12%
RNA-sequencing Data
12%
TANK-binding Kinase 1 (TBK1)
12%
Oncogene-induced Replication Stress
12%
Tumor mutational Burden
12%
METABRIC
12%
Biochemistry, Genetics and Molecular Biology
Genome Instability
100%
Immunocompetent Cell
100%
Cell Infiltration
100%
Oncogene C Myc
60%
CD4
40%
CD20
40%
STAT1
40%
Cyclin E1
40%
Clinical Trial
20%
Immune Checkpoints
20%
Homologous Recombination
20%
RNA Sequence
20%
Proto Oncogene
20%
Oncogene
20%
Cell Marker
20%
Immunology and Microbiology
Genomic Instability
100%
Immune Cell Infiltration
100%
Oncogene C Myc
75%
CD4
50%
CD20
50%
Cycline
50%
STAT1
50%
Immunocompetent Cell
25%
Immunotherapy
25%
Homologous Recombination
25%
RNA Sequence
25%
Proto Oncogene
25%
Oncogene
25%
Cell Marker
25%